Cargando…
Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension
BACKGROUND: Pulmonary vasodilators in general and prostacyclin therapy in particular, have markedly improved the outcome of patients with pulmonary arterial hypertension (PAH). As endothelial dysfunction is a key feature of PAH, and as endothelial progenitor cells (EPC) may contribute to vascular re...
Autores principales: | Smadja, David M., Mauge, Laetitia, Gaussem, Pascale, d’Audigier, Clément, Israel-Biet, Dominique, Celermajer, David S., Bonnet, Damien, Lévy, Marilyne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040815/ https://www.ncbi.nlm.nih.gov/pubmed/21049284 http://dx.doi.org/10.1007/s10456-010-9192-y |
Ejemplares similares
-
Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening
por: Levy, Marilyne, et al.
Publicado: (2013) -
Correction: Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening
por: Levy, Marilyne, et al.
Publicado: (2014) -
Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells
por: Smadja, David M, et al.
Publicado: (2008) -
Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation
por: Kazemi, Zahra, et al.
Publicado: (2016) -
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021)